Pfizer: Who Will Pay $14B for Advil?

Credit Suisse’s Vamil Divan says Pfizer’s consumer products unit is worth as much as $13.9 billion as the pharmaceutical giant considers a sale or spin off.
Source: Barrons

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>